Federal rule
would allow doctors to issue 90-day supply of painkillers

SUN SENTINEL
By HOPE YEN
Associated Press
September 6, 2006, 4:10 PM EDT
WASHINGTON -- People taking Oxycontin,
codeine and other powerful painkillers for chronic
pain could get a 90-day supply, under a proposal Wednesday
that would let patients avoid repeated doctor visits
to get more than 30-day prescriptions.
Unless a patient makes another office
visit, doctors now cannot refill the schedule II controlled
substances because they can be abused by addicts.
Current law is silent on the question of multiple
prescriptions for a drug that are issued by a doctor
in a single office visit.
The new proposal, subject to 60 days
of public comment, makes clear that doctors could
prescribe up to a 90-day supply without fear of prosecution.
Doctors have complained that strict regulation by
the Drug Enforcement Administration forced them to
limit prescriptions to a 30-day supply and leave patients
untreated.
``Today's policy statement reaffirms
that DEA wants doctors to treat pain as is appropriate
under accepted medical community standards,'' the
agency's chief, Karen Tandy, said at a news briefing.
``Physicians acting in accordance with accepted medical
practice should be confident that they will not be
criminally charged,'' Tandy said.
A broader debate in recent years has
questioned the proper role of federal law enforcement
in monitoring doctors' prescription decisions. The
Supreme Court this year ruled against a Justice Department
attempt to use the Controlled Substances Act to punish
Oregon doctors who helped patients commit suicide.
The number of physicians charged under
that law has risen from 38 in 2003 to 67 in 2005.
Meanwhile, about 6 million people _ including one
in 10 high school seniors _ currently abuse controlled
substance prescription drugs, according to the DEA.
At the briefing, Tandy sought to ease
distrust of the DEA among doctors, noting that the
agency had listened to their concerns in easing prescription
rules.
In many cases, doctors had already been
issuing multiple prescriptions since the law was silent
on the matter. The rule change would give them ease
of mind that they won't be prosecuted for doing so.
In addition, the DEA's Web site will
offer a new page that will spell out the number of
prosecutions each year and the circumstances in which
they were charged to avoid an undue chilling effect.
``We believe that the statement and
proposed rule will help the medical professional ensure
that only patients who need medication for pain relief
get it,'' Tandy said.
